Cargando…

Complete Remission of Advanced Hepatocellular Carcinoma in a Patient With Ulcerative Colitis Treated With Atezolizumab and Bevacizumab: A Case Report

In this case study, a 73-year-old man who had previously undergone colectomy had a history of ulcerative colitis and alcohol abuse and presented with fatigue, weight loss, and a liver lesion. After a biopsy, he was diagnosed with stage IV-A hepatocellular carcinoma with poor differentiation and cirr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pentapati, Swetha, Caucci, Stephen, Balmuri, Shravya, Devarkonda, Vishal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Internal Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290901/ https://www.ncbi.nlm.nih.gov/pubmed/37366434 http://dx.doi.org/10.7759/cureus.39538

Ejemplares similares

Novel Approach in Cardiac Sarcoidosis: A Case Report Highlighting Abatacept as a Promising Treatment Option
por: Venkataraj, Maamannan, et al.
Publicado: (2023)

Transforming Acute Myeloid Leukemia Treatment Through Next-Generation Sequencing: A Single-Center Experience
por: Devarkonda, Vishal, et al.
Publicado: (2023)

Hepatocellular carcinoma with gastric adenocarcinoma treated with atezolizumab and bevacizumab
por: Suga, Takayoshi, et al.
Publicado: (2023)

Atezolizumab, a PD-L1 Inhibitor: An Association of Bleeding Gastric Ulcer With Its Use
por: Bapatla, Anusha, et al.
Publicado: (2021)

Effectiveness of Fecal Microbiota Transplantation Treatment in Patients With Recurrent Clostridium difficile Infection, Ulcerative Colitis, and Crohn’s Disease: A Systematic Review
por: Jaramillo, Arturo P, et al.
Publicado: (2023)

Acute Graft Versus Host Disease After Kidney-Pancreas Transplant
por: Lopez, James, et al.
Publicado: (2023)

Visual Outcome of Plasma Exchange in Optic Neuritis Associated With Flu Vaccination: A Case Report
por: Bouchette, Philip, et al.
Publicado: (2022)

Fibrolamellar hepatocellular carcinoma treated with atezolizumab and bevacizumab: two case reports
por: AL Zahrani, Ali, et al.
Publicado: (2021)

A Case of Pseudoprogression in Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab
por: Watanabe, Yukinobu, et al.
Publicado: (2021)

Use of Azathioprine in Ulcerative Colitis: A Comprehensive Review
por: Mallick, Bipadabhanjan, et al.
Publicado: (2022)

Listeria Monocytogenes Septicemia in the Setting of an Ulcerative Colitis Flare
por: Seraphin, Michael J, et al.
Publicado: (2022)

A Rare Case of Pseudomembrane-Associated Ulcerative Colitis
por: Ahmed-Khan, Mohammad A, et al.
Publicado: (2022)

Organizing Pneumonia and Ulcerative Colitis: A Relationship To Remember
por: Pereira, Sergio, et al.
Publicado: (2023)

Complete Remission of Bone Metastases in Renal Cell Carcinoma with Nivolumab
por: Vuyyala, Sowjanya, et al.
Publicado: (2019)

Alpha-Fetoprotein as a Potential Surrogate Biomarker for Atezolizumab + Bevacizumab Treatment of Hepatocellular Carcinoma
por: Zhu, Andrew X., et al.
Publicado: (2022)

A case of unresectable combined hepatocellular and cholangiocarcinoma treated with atezolizumab plus bevacizumab
por: Saito, Naoto, et al.
Publicado: (2022)

An Infrequent Extraintestinal Manifestation of Ulcerative Colitis: Pulmonary Necrobiotic Nodules
por: Myer, Adam S, et al.
Publicado: (2020)

Bilateral Pulmonary Embolism in a Hospitalized Ulcerative Colitis Patient
por: Medgyesy, Karen, et al.
Publicado: (2022)

Ulcerative Colitis-Induced Colorectal Carcinoma: A Deleterious Concatenation
por: Rivera, Ana P, et al.
Publicado: (2022)

Mesalazine-Induced Interstitial Nephritis in a Patient With Ulcerative Colitis
por: da Cunha Marques, José, et al.
Publicado: (2022)

Effectiveness of Mesalamine in Patients With Ulcerative Colitis: A Systematic Review
por: Santos, Yurianna, et al.
Publicado: (2023)

Complete Endoscopic and Histopathological Remission of Mantle Cell Lymphoma of the Gastrointestinal Tract
por: Mohy-ud-din, Nabeeha, et al.
Publicado: (2019)

Memory T Cell Subpopulations as Early Predictors of Remission to Vedolizumab in Ulcerative Colitis
por: Gonzalez-Vivo, Maria, et al.
Publicado: (2022)

Pylephlebitis as a Rare Complication of Ulcerative Colitis: A Case Report
por: Hamera, Leonard, et al.
Publicado: (2019)

Transdermal Nicotine as a Treatment Option for Ulcerative Colitis: A Review
por: Kannichamy, Vishmita, et al.
Publicado: (2020)

Pulmonary Necrobiotic Nodules at Time of Diagnosis in a Patient with Ulcerative Colitis
por: Kellish, Alec, et al.
Publicado: (2020)

A Rare Case of New-Onset Ulcerative Colitis in a Nonagenarian
por: Emeasoba, Emmanuel U, et al.
Publicado: (2022)

Surgical Treatment in Ulcerative Colitis, Still Topical: A Narrative Review
por: Slonovschi, Eduard, et al.
Publicado: (2023)

A Case of Metastatic Pancreatic Adenocarcinoma in Complete Remission Using Chemotherapy and Immunotherapy
por: Atiq, Saad, et al.
Publicado: (2021)

Hepatic Events and Viral Kinetics in Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab
por: Hsu, Chiun, et al.
Publicado: (2022)

Two cases of unresectable hepatocellular carcinoma treated via atezolizumab and bevacizumab combination therapy
por: Tsunemitsu, Ryosuke, et al.
Publicado: (2023)

Feasibility of additional radiotherapy in patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab
por: Kim, Tae Hyun, et al.
Publicado: (2023)

The Efficacy of Currently Licensed Biologics for Treatment of Ulcerative Colitis: A Literature Review
por: Awan, Humza, et al.
Publicado: (2023)

Myositis as an Extraintestinal Manifestation of Ulcerative Colitis: A Case Report and Literature Review
por: Nagi, Talwinder K, et al.
Publicado: (2023)

Unraveling the Synergy between Atezolizumab and Bevacizumab for the Treatment of Hepatocellular Carcinoma
por: Brackenier, Cedric, et al.
Publicado: (2023)

Adjuvant atezolizumab-bevacizumab after curative therapy for hepatocellular carcinoma
por: Kudo, Masatoshi
Publicado: (2023)

Case Report: Atezolizumab plus bevacizumab for combined hepatocellular-cholangiocarcinoma
por: Satake, Tomoyuki, et al.
Publicado: (2023)

Adjuvant Atezolizumab-Bevacizumab after Resection or Ablation for Hepatocellular Carcinoma
por: Kudo, Masatoshi
Publicado: (2023)

Predicting Outcomes of Atezolizumab and Bevacizumab Treatment in Patients with Hepatocellular Carcinoma
por: Han, Ji Won, et al.
Publicado: (2023)

A Unique Triad: Ulcerative Colitis, Primary Sclerosing Cholangitis, and Autoimmune Hemolytic Anemia
por: Naqvi, Syeda, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6k2v9e3759seh800kclf0vkdv5